| Target Price | $31.62 |
| Price | $23.69 |
| Potential |
33.47%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Privia Health Group 2026 .
The average Privia Health Group target price is $31.62.
This is
33.47%
register free of charge
$38.85
63.99%
register free of charge
$23.23
1.94%
register free of charge
|
|
| A rating was issued by 27 analysts: 24 Analysts recommend Privia Health Group to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2026 of
33.47%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.74 | 3.56 |
| 4.74% | 104.97% | |
| EBITDA Margin | 1.40% | 3.43% |
| 14.82% | 145.60% | |
| Net Margin | 0.83% | 0.46% |
| 40.48% | 44.49% |
22 Analysts have issued a sales forecast Privia Health Group 2025 . The average Privia Health Group sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Privia Health Group EBITDA forecast 2025. The average Privia Health Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Privia Health Group Analysts have issued a net profit forecast 2025. The average Privia Health Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.11 | 0.13 |
| 42.11% | 18.18% | |
| P/E | 176.53 | |
| EV/Sales | 0.69 |
22 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is
This results in the following potential growth metrics and future valuations:
Privia Health Group...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Dec 04 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Dec 04 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


